Company Filing History:

8 out of 266

Pierre Fabre Medicament

Years Active: 1993-2014

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8808999 - Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof (2014-08-19),

2. 8168410 - Anti-IGF-IR antibodies and uses thereof (2012-05-01),

3. 8101180 - Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof (2012-01-24),

4. 7914784 - Anti-IGF-IR antibodies and uses thereof (2011-03-29),

5. 7553485 - Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof (2009-06-30),

6. 7241444 - Anti-IGF-IR antibodies and uses thereof (2007-07-10),

7. 6127377 - Vinca alkaloid antimitotic halogenated derivatives (2000-10-03),

8. 5385931 - Sulfonamides derived from benzocyclic or benzoheterocyclic acids, their (1995-01-31),

9. 5182273 - Spirocyclic N, O derivatives of cyclotriphosphazenes and their use in (1993-01-26),

Title: Innovations and Contributions of Inventor Alain Duflos

Introduction

Alain Duflos is a notable inventor based in Labruguiere, France. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting insulin-like growth factor receptors. With a total of 9 patents to his name, Duflos has established himself as a key figure in medical research and innovation.

Latest Patents

Among his latest patents is the invention titled "Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof." This invention relates to methods for identifying modulators of IGF-IR and hybrid-R by utilizing humanized antibodies. Another significant patent is "Anti-IGF-IR antibodies and uses thereof," which focuses on novel antibodies that specifically bind to the human insulin-like growth factor I receptor IGF-IR. These antibodies are designed to inhibit the tyrosine kinase activity of the IGF-IR receptor and have potential applications in the treatment of cancers that overexpress this receptor.

Career Highlights

Throughout his career, Alain Duflos has worked with prominent companies in the pharmaceutical industry, including Pierre Fabre Medicament and Adir Et Compagnie. His work has contributed to advancements in cancer treatment and diagnostics, showcasing his commitment to improving healthcare through innovative solutions.

Collaborations

Duflos has collaborated with esteemed colleagues such as Liliane Goetsch and Nathalie Corvaia. These partnerships have further enhanced his research and development efforts, leading to impactful innovations in the field.

Conclusion

Alain Duflos is a distinguished inventor whose work in biotechnology has led to significant advancements in cancer treatment. His innovative patents and collaborations reflect his dedication to improving medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.